• 1
    LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr Rowell N, Wollheim F: Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15: 202205, 1988
  • 2
    Masi AT: Classification of systemic sclerosis (scleroderma): relationship of cutaneous subgroups in early disease to outcome and serologic reactivity (editorial). J Rheumatol 15: 894895, 1988
  • 3
    Bennett R, Bluestone R, Holt PJL, Bywaters EGL: Survival in scleroderma. Ann Rheum Dis 30: 581588, 1971
  • 4
    Medsger TA Jr Masi AT, Rodnan GP, Benedek TG, Robinson H: Survival with systemic sclerosis (scleroderma): a life-table analysis of clinical and demographic factors in 309 patients. Ann Intern Med 75: 369376, 1971
  • 5
    Medsger TA Jr: Scleroderma: recent advances in the treatment of progressive systemic sclerosis. Orthop Rev 13: 6980, 1984
  • 6
    Giordano M, Valentini G, Migliaresi S, Picillo V, Vatti M: Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis. J Rheumatol 13: 911916, 1986
  • 7
    Barnett AJ, Miller MH, Littlejohn GO: A survival study of the patients diagnosed over 30 years (1953–1983): the value of a simple cutaneous classification in the early stages of the disease. J Rheumatol 15: 276283, 1988
  • 8
    Furst DE, Clements PJ, Hillis S, Lachenbruch PA, Miller BL, Sterz MG, Paulus HE: Immunosuppression with chlorambucil, versus placebo, for scleroderma: results of a three-year, parallel, randomized, double-blind study. Arthritis Rheum 32: 584593, 1989
  • 9
    Furst DE, Clements PJ, Saab M, Sterz MG, Paulus HE: Clinical and serological comparison of 17 chronic progressive systemic sclerosis (PSS) and 17 CREST syndrome patients matched for sex, age, and disease duration. Ann Rheum Dis 43: 794811, 1984
  • 10
    Rodnan GP, Lipinski E, Luksick J: Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma. Arthritis Rheum 22: 130140, 1979
  • 11
    Steen VD, Medsger TA Jr Rodnan GP: D-penicillamine therapy in progressive systemic sclerosis (scleroderma): a retrospective analysis. Ann Intern Med 97: 652659, 1982
  • 12
    Kahaleh MB, Suttany GL, Smith EA, Huffstutter JE, Loadholt CB, LeRoy EC: A modified scleroderma skin scoring method. Clin Exp Rheumatol 4: 367369, 1986
  • 13
    Medsger TA Jr Steen VD, Ziegler G, Rodnan GP: The natural history of skin involvement in progressive systemic sclerosis (abstract). Arthritis Rheum 23: 720721, 1980
  • 14
    Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23: 581590, 1980
  • 15
    Cox DR: Regression models and lifetables. J R Stat Soc (B) 34: 187220, 1972
  • 16
    Steen VD, Medsger TA Jr Oscal TA, Ziegler GL, Shapiro AP, Rodnan GP: Factors predicting development of renal involvement in progressive systemic sclerosis. Am J Med 76: 779786, 1984
  • 17
    Lally EV, Jimenez SA, Kaplan SR: Progressive systemic sclerosis: mode of presentation, rapidly progressive disease course, and mortality based on an analysis of 91 patients. Semin Arthritis Rheum 18: 113, 1988